ASCO: TKI Offers Hope in Small Cell Lung Cancer

CHICAGO (MedPage Today) -- Maintenance therapy with the oral tyrosine kinase inhibitor sunitinib (Sutent) delayed relapse after chemotherapy in patients with extensive small cell lung cancer, a researcher said here. via MedPageToday.com - medical news plus CME for physicians Read More Here..

For a Free Step By Step Guide for Dating Dos and Don'ts check http://end2endwebs.com

Lake forest health and fitness http://healthandfitness1blog.blogspot.com/2013/06/asco-tki-offers-hope-in-small-cell-lung.html